Canton Hathaway’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-74
Closed -$36K 239
2022
Q2
$36K Hold
74
0.01% 187
2022
Q1
$36K Hold
74
0.01% 208
2021
Q4
$34K Hold
74
0.01% 222
2021
Q3
$28K Buy
+74
New +$28.1K 0.01% 243

Other funds holding ELV

Canton Hathaway's ELV Position: Q3 2022 in Review

Canton Hathaway sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 74 shares — an estimated $36K sold.

Canton Hathaway first reported a position in ELV in Q3 2021 and held it in 4 quarters. The position peaked at $36K in Q2 2022. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Canton Hathaway reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Canton Hathaway sold 74 Elevance Health shares in Q3 2022, an estimated $36K.
  • Canton Hathaway first reported a position in Elevance Health in Q3 2021 and held it in 4 quarters.
  • Canton Hathaway's Elevance Health position peaked at $36K in Q2 2022.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Canton Hathaway's 13F filing for Q3 2022, filed 17 Oct 2022.